Peripheral Vascular Devices | Market Insights | Asia Pacific (Supplemental) | 2021
The Asia Pacific market for PV devices will grow modestly through 2029, fueled by the growing PAD population and the adoption of premium devices like DCBs, DES, and powered thrombectomy devices. However, lack of reimbursement, cost constraints, and the impact of COVID-19 pandemic will limit market growth to some extent.
This Medtech 360 Report provides high-level market metrics for PV devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.
